The stock of Zai Lab Limited ADR (ZLAB) has seen a 28.06% increase in the past week, with a 37.95% gain in the past month, and a 8.37% flourish in the past quarter. The volatility ratio for the week is 4.87%, and the volatility levels for the past 30 days are at 4.55% for ZLAB. The simple moving average for the last 20 days is 37.87% for ZLAB stock, with a simple moving average of -8.21% for the last 200 days.
Is It Worth Investing in Zai Lab Limited ADR (NASDAQ: ZLAB) Right Now?
The 36-month beta value for ZLAB is also noteworthy at 1.14. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 2 rating it as “overweight,” 1 rating it as “hold,” and 0 rating it as “sell.”
The public float for ZLAB is 98.19M, and at present, short sellers hold a 4.15% of that float. The average trading volume of ZLAB on May 09, 2024 was 605.25K shares.
ZLAB) stock’s latest price update
The stock price of Zai Lab Limited ADR (NASDAQ: ZLAB) has surged by 28.21 when compared to previous closing price of 16.57, but the company has seen a 28.06% gain in its stock price over the last five trading sessions. Business Wire reported 2024-04-15 that SHANGHAI & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that it will report financial results for the first quarter of 2024 and recent corporate updates, after the closing of the U.S. equity markets on Wednesday, May 8, 2024. The Company will host a live conference call and webcast on Thursday, May 9, 2024, at 8:00 a.m. ET (8:00 p.m. HKT). Conference Call and Webcast Information Listeners may access the live webcast by visiting the Company’s webs.
Analysts’ Opinion of ZLAB
Many brokerage firms have already submitted their reports for ZLAB stocks, with Morgan Stanley repeating the rating for ZLAB by listing it as a “Overweight.” The predicted price for ZLAB in the upcoming period, according to Morgan Stanley is $47.50 based on the research report published on December 14, 2023 of the previous year 2023.
Cantor Fitzgerald, on the other hand, stated in their research note that they expect to see ZLAB reach a price target of $70. The rating they have provided for ZLAB stocks is “Overweight” according to the report published on August 10th, 2023.
Macquarie gave a rating of “Outperform” to ZLAB, setting the target price at $64 in the report published on January 21st of the previous year.
ZLAB Trading at 25.87% from the 50-Day Moving Average
After a stumble in the market that brought ZLAB to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -46.22% of loss for the given period.
Volatility was left at 4.55%, however, over the last 30 days, the volatility rate increased by 4.87%, as shares surge +39.36% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +0.57% upper at present.
During the last 5 trading sessions, ZLAB rose by +26.09%, which changed the moving average for the period of 200-days by -31.33% in comparison to the 20-day moving average, which settled at $15.70. In addition, Zai Lab Limited ADR saw -22.26% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ZLAB starting from Reinhart Harald, who sale 2,105 shares at the price of $15.67 back on Apr 04 ’24. After this action, Reinhart Harald now owns 51,800 shares of Zai Lab Limited ADR, valued at $32,992 using the latest closing price.
Smiley Joshua L sale 1,988 shares at $15.67 during a trade that took place back on Apr 04 ’24, which means that Smiley Joshua L is holding 28,684 shares at $31,158 based on the most recent closing price.
Stock Fundamentals for ZLAB
Current profitability levels for the company are sitting at:
- -1.37 for the present operating margin
- 0.64 for the gross margin
The net margin for Zai Lab Limited ADR stands at -1.18. The total capital return value is set at -0.44. Equity return is now at value -36.34, with -29.66 for asset returns.
Based on Zai Lab Limited ADR (ZLAB), the company’s capital structure generated 0.02 points at debt to capital in total, while cash flow to debt ratio is standing at -13.08. The debt to equity ratio resting at 0.02. The interest coverage ratio of the stock is 17.99.
Currently, EBITDA for the company is -358.84 million with net debt to EBITDA at 2.21. When we switch over and look at the enterprise to sales, we see a ratio of 4.89. The receivables turnover for the company is 4.08for trailing twelve months and the total asset turnover is 0.26. The liquidity ratio also appears to be rather interesting for investors as it stands at 4.63.
Conclusion
In summary, Zai Lab Limited ADR (ZLAB) has had a mixed performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
